Company attributes
Other attributes
Fountain Therapeutics is a biopharmaceutical company developing and discovering treatment for age-related human diseases that is headquartered in San Francisco, California and was founded in 2018 by Thomas Rando, Joseph Rodgers, and Tom Cheung. The company uses deep learning to help gain insight into effective therapeutics treatments for treating the diseases of aging and to provide anti-aging treatments. Fountain Therapeutics is C-Corp established in Delaware and is categorized as a company working under Commercial Biotechnical research.
On May 7, 2018 Fountain Therapeutics announced raising $5 million in series A funding from Nan Fung Life Sciences.
On February 12, 2020 Fountain Therapeutics announced raising $6 million in series A-1 funding from Khosla Ventures (lead investor) and Nan Fung Life Sciences. The company plans on using their series A-1 funding to hire more senior leadership within the company and to improve the company's platform for developing novel therapeutics in preclinical animal testing models.
